Investigating how mild brain injuries lead to Alzheimer's disease through a specific protein pathway
The molecular intersection of tau, TBI, and PERK
This study is looking at how small repeated brain injuries might lead to changes in the brain that are linked to Alzheimer's disease, focusing on a protein called PERK that can cause problems if it's active for too long, and it's designed for anyone interested in understanding the risks of Alzheimer's after brain injuries.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project ID | NIH-11088779 on NIH RePORTER |
What this research studies
This research explores the connection between mild repetitive traumatic brain injury (mrTBI) and the development of tau pathology linked to Alzheimer's disease. The study focuses on the role of a protein called PERK, which is activated during brain injury and can lead to cell death if activated for too long. Using mouse models, researchers will examine how different intensities and timings of mrTBI affect PERK activation and the resulting tau protein aggregation. The goal is to understand the molecular mechanisms that increase the risk of Alzheimer's disease following brain injuries.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced mild repetitive traumatic brain injuries and are at risk for developing Alzheimer's disease.
Not a fit: Patients who have not experienced any form of brain injury or those with advanced Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing or treating Alzheimer's disease in individuals with a history of brain injuries.
How similar studies have performed: Other research has shown promising results in understanding the relationship between brain injuries and Alzheimer's disease, making this approach both relevant and potentially impactful.
Where this research is happening
Gainesville, United States
- University of Florida — Gainesville, United States (Active)
Researchers
- Principal investigator: Abisambra, Jose Francisco — University of Florida
- Study coordinator: Abisambra, Jose Francisco
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.